Summary
Machine-generated summaryThe Servicio Murciano de Salud, through its purchasing board, awarded a contract for exclusive medicines containing the active substances erenumab, fremanezumab and galcanezumab. The supply covers erenumab 140mg and 70mg prefilled pens, fremanezumab 225mg prefilled syringes and prefilled pens, and galcanezumab 120mg prefilled pens, all injectable solutions. The winners are NOVARTIS FARMACÉUTICA, S.A, TEVA PHARMA, S.L.U. and ORGANON SALUD, S.L. The awarded value is EUR 3,508,147.50, which is 63% below the estimated value of EUR 9,471,998.25. The award date was 2026-08-12.
Description
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 4 days ago
More from this buyer
Full buyer profile1 open tender right now
Recent awards
- Suministro de dispositivos de pulpa de papel para la recogida de orina y desechos orgánicos y equipos de trituración.
- Reactivos de laboratorio - Equipos, reactivos y material necesario para la realización de la serología microbiológica
- SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS con principios activos daratumumab, talquetamab, glecaprevir/pibrentasvir, epcoritamab, atogepant, rimegepant, retlecitinib y cemiplimab de varios laboratorios farmacéuticos.
Similar tenders
1
day left
€30,000
est. value
1
day left
€832,886
est. value
1
day left
€99,000
est. value
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €10,245,261
- Buyer track record on Aperlena
- 63 notices tracked · 34 awarded
- €62,419,432 in awarded contracts
Never miss a tender like this
756 new notices in Medical equipment & pharmaceuticals in Spain in the last 7 days. Get an email when new ones appear. Free.
Set up my alert